intro to medical oncology – Flashcards

Unlock all answers in this set

Unlock answers
question
what is nowell's hypothesis?
answer
genetic instability inside the cell can lead to genetic abnormalities
question
how can genetic abnormalities be aquired?
answer
through viral, environmental, chemotherapy and other means
question
how does oncogenesis occur?
answer
a genetic abnormality is aquired, it expands to a clone, it loses contact inhibition (grows on other cells), cells build up and form a tumor, clones aquire additional abnormalities and expand to subclone which then becomes malignant through transformation and loses the ability for apoptosis/contact inhibition -> growth continues w/out any controls
question
why are malignant genes selected for in cells?
answer
because of their ability to continue to populate
question
how many steps does the "double hit" hypothesis really consist of
answer
it takes 7 genetic changes from a normal cell to a drug resistant metastasis. there can be some inherent abnormality within the cell – this alone is not enough to cause malignant transformation - however, if the cell is “hit” again or exposed to a second damage, in combination with the genetic condition, the cell will become cancerous.
question
what is ultimately problematic about tumors?
answer
tumors continue to grow and take up metabolic resources, impinge on other structures and ultimately metastasize into other areas, if this last step could be controlled - pts could live like other pts with chronic diseases
question
what are skipper's laws?
answer
the doubling time of proliferating cells is a constant (death results when malignant cells reach a critical level - usually after ~ 30 doubling times. the shorter your doubling time, the shorter your life expectancy) cell kill by chemotherapy follows 1st order kinetics (the % of cells killed at a given drug dose is constant, regardless of tumor size. a log-kill is one exponent-worth of tumor cell reduction: like a cell population at 10^9 being brought down to 10^8 is a 1 log-kill)
question
what is the gompertzian growth curve? how do malignant cells get around this?
answer
a nonexponential growth pattern based on size of tumor and nutrient availability (growth will level off as blood supply/nutrient level drops off). malignant cells try to get around this through angiogenesis or makes VEGF receptors to aid in its growth, and also makeing VEGF for autostimulation. malignant cells will also be harder to treat due to lack of blood supply (how chemotherapy travels) and longer existence at G0
question
what is the goldie-coldman hypothesis? what does it mean in practice?
answer
a mathematical model that predicts that tumor cells mutate to a resistant phenotype at a rate dependent on their intrinsic genetic instability - according to this hypothesis, even the smallest detectable cancers contain at least 1 drug-resistant clone, and therefore the best chance of a cure is to use all effective chemotherapy drugs. in practice this = using 2+ non-cross-resistant chemotherapy drugs in alternating cycles
question
what is an example of multidrug tx working?
answer
tumors down-regulate expression of carrier proteins that methotrexate uses and are thus resistant to it. cisplatin is then administered and when cells develop resistance to it, they are susceptible to methotrexate again
question
what is stage 4 cancer? why is it so deadly?
answer
stage 4/metastatic cancer is where survival is very low (kills 90% of cancer patients) and other organ structures can become obstructed
question
what is the multistep process of metastasis?
answer
invasion, intravasation (getting into blood/lymph circulation), survival in circulation, extravasion, and proliferation/angiogenesis at the new site (eventually this new tumor can metastasize)
question
what is basically needed for cancer cells to grow?
answer
oxygen and blood supply
question
is metastatic cancer curable?
answer
no
question
what is the first step of systemic cancer therapy?
answer
set goals to either cure, prolong survival or provide palliative care
question
when is primary/induction therapy used?
answer
primary/induction therapy is used when local therapy (sx/radiation) is inadequate and the disease has spread beyond local therapy's scope. it works to bring the disease back to a point where it can be locally treated or to where it is essentially gone.
question
when is adjuvant therapy used?
answer
when disease has possibly spread outside the area of local control and there is a high risk of recurrence due to micrometastatic disease.
question
what are the types of systemic therapy?
answer
cytotoxic (basically poison - hope is to kill more bad cells than good), hormonal (ex: tamoxifen w/breast CA), targeted (specific to the tumor like radioactive antigens), immunological (helps immune system fight off tumors like kidney CA)
question
what are cytotoxic chemotherapeutic agents?
answer
antimetabolities, mitotic inhibitors, alkylating agents, antibiotics, and topoisomerase inhibitors
question
what do antimetabolities do? are they specific to a cell cycle?
answer
antimetabolites are analogues of normal metabolites that affect RNA, DNA synthesis (folic acid, pyrimidine, cytidine and purine analogues) that work in the *S phase of the cell cycle: methotrexate, 5-fluorouracil and cytosine arabinoside are examples
question
what are mitotic inhibitors? are they specific to a cell cycle?
answer
mitotic inhibitors bind to tubulin and arrest metaphase, some are mitotic spindle poisons stabilizing the microtubules/others disrupt the polymeration of microtubes. these work in the M phase (sometimes are only used with S phase). examples: vincristine, pacletaxel, docetaxel
question
what are alkylating agents? are they specific to a cell cycle?
answer
these contribute alkyl groups to biological macromolecules such as DNA and cause cross-linking/strand breaks which the body attempts to repair, but cannot and dies. these are not specific to a cell cycle phase
question
how do antibiotics kill tumor cells? are they specific to a cell cycle?
answer
antibiotics insert between base pairs and block synthesis of DNA, RNA or both (5-flurouracil affects both – these are the ones that are most effective) these are not specific to a cell cycle. examples; doxorubicin, bleomycin (“-rubicin” is an antibiotic)
question
what are topoisomerase inhibitors? are they specific to a cell cycle?
answer
topoisomerase inhibitors inhibit enzymes that break and repair DNA strands, they work in the S phase and examples include etoposide and camptothecins
question
why are cell cycle specific drugs given continously?
answer
the drug is given continuously to kill the cells in that cycle at that time (kill those in the S phase that were previously in the M phase and vice versa
question
what are considerations for chemotherapy drugs given in combination?
answer
drug combinations are used to make sure mechanisms of action are different to prevent resistance, however care must be given to not combine toxicities or drugs have different metabolisms so they don't affect each other's concentrations
question
what are benefits to giving alternating drug therapies?
answer
this can function as a 1-2 punch where drug A is given to affect cells a certain way, then adminstration is switched to drug B, once the cells targeted by drug A start coming back, drug A is re-administered
question
what is the maximal tolerated dose (MTD)?
answer
this is tested by giving a drug to a small group of pts in increasing increments, and once you see the beginnings of toxicity you know to keep the dose below that and do not exceed it. in tx of pts, you want to get a dose that will give the greatest effects with least amount of side effects (safety index).
question
how long should chemotherapy be given for?
answer
the shortest possible time, do not want high toxic doses for prolonged periods
question
what is dose dense/intense therapy?
answer
instead of administering chemo, burning out WBCs and waiting 3-4 wks for them to return, chemo doses can be given now in shorter intervals because GCSF (granulocyte colony stimulating factor) can bring WBC counts faster and tx is more effective
question
what is a toxicity associated with antracyclines?
answer
cardiac toxicity
question
what is a toxicity associated with taxanes?
answer
neurological toxicity
question
what is a toxicity associated with alkylating agents?
answer
secondary malignancy
question
what is a toxicity associated with cisplatin?
answer
renal/neurotoxicity
question
what is a toxicity associated with cyclophosphamide?
answer
hemorrhagic cystitis because of the drug metabolites
question
how is toxicity prevented?
answer
anti-emetics for nausea, oral care for mouth sores, G-CSF to increase white cell count, hydration and diuresis to keep the flow going in kidney and bladder (remove irritation from bladder), cytoprotectants (ex: WR-2721 aka amifostine) drugs that protect normal cells from chemotherapy and/or radiation therapy
question
what are some examples of endocrine therapies targeting CA?
answer
castration, SERMs (selective estrogen receptor modulators like tamoxifen), AI (aromatase inhibitors), anti-androgens, GnRH analogues (for prostate CA)
question
what can be used for CA immunotherapy?
answer
IFN, IL-2
question
what are examples of targeted therapy?
answer
TKI, EGFR, anti-VEGF, proteosome inhibitors, mAb
question
what does TKI do?
answer
TKIs (tyrosine kinase inhibitors) show a benefit in renal cell carcinomas
question
what is EGFR used for?
answer
EGFR is as good, if not better, than classic chemo for certain tumors (limited) and can also be used after chemo for certain patients
question
what is anti-VEGF used for?
answer
some tumors are highly dependent on VEGF, many studies show anti-VEGF treatments significantly increase survival
question
what cancers are proteosome inhibitors used on?
answer
these are used on multiple myelomas and work very well
question
what do mAb (monoclonal antibodies) do?
answer
mAbs like rituximab target lymphoma cells because they are abnormally marked cells and work exceptionally well
question
how can genetic factors be used to fight cancer?
answer
genetic factors target the genome and will turn off promoter regions so the malignant cell will be converted back to normal because the genetic abnormality is known
Get an explanation on any task
Get unstuck with the help of our AI assistant in seconds
New